Stock MEDS TRXADE HEALTH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. TRxADE HEALTH, Inc.

Equities

MEDS

US89846A4058

Market Closed - Nasdaq
Other stock markets
 21:30:00 03/05/2024 BST 		5-day change 1st Jan Change
6.29 USD +4.66% Intraday chart for TRxADE HEALTH, Inc. -0.32% +21.05%
04-22 TRxADE HEALTH, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
03-06 Top Midday Gainers MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
EF Hutton Assumes Trxade Health at Buy With $1.25 Price Target
MT
Maxim Adjusts Price Target on Trxade Health to $1.75 From $2.50, Maintains Buy Rating
MT
Inflation, Rate-Hike Concerns Push US Equity Futures Lower
MT
Maxim Adjusts Price Target for TRxADE Health to $4 From $7, Maintains Buy Rating
MT
Maxim Adjusts TRxADE HEALTH's Price Target to $7 from $11, Maintains Buy Rating
MT
TRXADE : National Securities Initiates Trxade Group at Buy with $15 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MEDS Stock
  4. News TRxADE HEALTH, Inc.
  5. Analyst Reco.